Matches in Wikidata for { <http://www.wikidata.org/entity/Q99616334> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q99616334 description "article scientifique publié en 2020" @default.
- Q99616334 description "artículu científicu espublizáu en setiembre de 2020" @default.
- Q99616334 description "scientific article published on 23 September 2020" @default.
- Q99616334 description "wetenschappelijk artikel" @default.
- Q99616334 description "наукова стаття, опублікована 23 вересня 2020" @default.
- Q99616334 name "FDA Approval Summary: Entrectinib for the treatment of NTRK-gene fusion solid tumors" @default.
- Q99616334 name "FDA Approval Summary: Entrectinib for the treatment of NTRK-gene fusion solid tumors" @default.
- Q99616334 type Item @default.
- Q99616334 label "FDA Approval Summary: Entrectinib for the treatment of NTRK-gene fusion solid tumors" @default.
- Q99616334 label "FDA Approval Summary: Entrectinib for the treatment of NTRK-gene fusion solid tumors" @default.
- Q99616334 prefLabel "FDA Approval Summary: Entrectinib for the treatment of NTRK-gene fusion solid tumors" @default.
- Q99616334 prefLabel "FDA Approval Summary: Entrectinib for the treatment of NTRK-gene fusion solid tumors" @default.
- Q99616334 P1433 Q99616334-4C16AB47-3A7C-4E5C-8D62-473F38782152 @default.
- Q99616334 P1476 Q99616334-ECFA75BB-EC66-4E9F-8FB7-460C07F898C1 @default.
- Q99616334 P2093 Q99616334-1C10BBEB-D160-4F42-B831-A0036AB5D676 @default.
- Q99616334 P2093 Q99616334-3D3CBB09-EF0F-4947-BD52-78BB92B90174 @default.
- Q99616334 P2093 Q99616334-56985CD9-C166-4012-B177-7528B82B17AB @default.
- Q99616334 P2093 Q99616334-777D99A5-B10B-4C55-A8B8-A0A834D8E835 @default.
- Q99616334 P2093 Q99616334-786DDEA8-707D-4815-BDF8-FC42FD7C3A1A @default.
- Q99616334 P2093 Q99616334-80477BE2-2C4F-47A5-8B5C-80B5A3043D10 @default.
- Q99616334 P2093 Q99616334-977E7B40-6489-4D72-8671-CB2D3F19213B @default.
- Q99616334 P2093 Q99616334-AB2FDC3A-01C5-4870-BE89-9FCE2216491C @default.
- Q99616334 P31 Q99616334-8D7AC543-BD8C-4E4B-A967-83E4B0DEAE56 @default.
- Q99616334 P356 Q99616334-B892CC28-6BA8-4B33-94AE-026FD1BBF712 @default.
- Q99616334 P50 Q99616334-91CC2312-6FCA-4E28-89BB-6131567DC542 @default.
- Q99616334 P50 Q99616334-9681B49C-C18C-4D26-AAF9-31B3EAFFF813 @default.
- Q99616334 P577 Q99616334-3BBA5ACA-5897-47C1-99AC-12A9E65E681A @default.
- Q99616334 P698 Q99616334-65C4B3DC-9415-476B-9EF4-66E5262C5B40 @default.
- Q99616334 P356 1078-0432.CCR-20-2771 @default.
- Q99616334 P698 32967940 @default.
- Q99616334 P1433 Q332253 @default.
- Q99616334 P1476 "FDA Approval Summary: Entrectinib for the treatment of NTRK-gene fusion solid tumors" @default.
- Q99616334 P2093 "Guoxiang Shen" @default.
- Q99616334 P2093 "Hong Zhao" @default.
- Q99616334 P2093 "Leigh Marcus" @default.
- Q99616334 P2093 "Olen Stephens" @default.
- Q99616334 P2093 "Patricia Keegan" @default.
- Q99616334 P2093 "Richard Pazdur" @default.
- Q99616334 P2093 "Stephanie Aungst" @default.
- Q99616334 P2093 "Whitney S Helms" @default.
- Q99616334 P31 Q13442814 @default.
- Q99616334 P356 "10.1158/1078-0432.CCR-20-2771" @default.
- Q99616334 P50 Q99616332 @default.
- Q99616334 P50 Q99616333 @default.
- Q99616334 P577 "2020-09-23T00:00:00Z" @default.
- Q99616334 P698 "32967940" @default.